The annual meeting of the American College of Rheumatology was held this year from Nov. 6 to 11 in Orlando, Florida, and attendees included rheumatology specialists, physicians, scientists, and other health professionals. […]
The annual meeting of the American College of Rheumatology was held this year from Nov. 6 to 11 in Orlando, Florida, and attendees included rheumatology specialists, physicians, scientists, and other health professionals. The conference featured presentations focusing on the latest advances in the diagnosis and treatment of arthritis as well as other rheumatic and musculoskeletal diseases.
ACR: Brepocitinib Yields Improvements in Cutaneous Sarcoidosis
TUESDAY, Nov. 17, 2026 (HealthDay News) — For patients with cutaneous sarcoidosis, brepocitinib is associated with dose-dependent and clinically meaningful improvements, according to a study published online Nov. 10 in JAMA Dermatology to coincide with the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.
ACR: Bimekizumab Demonstrates Superior Results to Risankizumab in Psoriatic Arthritis
TUESDAY, Nov. 17, 2026 (HealthDay News) — For patients with psoriatic arthritis, bimekizumab appears to be superior to risankizumab in terms of ≥50 percent improvement in American College of Rheumatology response criteria at week 16, with the benefits sustained to week 24, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.
ACR: CAR T-Cell Therapy Shows Promise for Patients With Lupus
MONDAY, Nov. 16, 2026 (HealthDay News) — For patients with systemic lupus erythematosus, chimeric antigen receptor T-cell therapy is associated with consistent reductions in disease activity, according to research presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.
ACR: Retatrutide Beneficial in Adults With Painful Knee OA, Obesity
THURSDAY, Nov. 12, 2026 (HealthDay News) — Retatrutide treatment results in significantly greater reductions in the Western Ontario and McMaster Universities Osteoarthritis Index pain score and in body weight compared with placebo among adults with painful knee osteoarthritis and obesity, according to a study published online Nov. 8 in the New England Journal of Medicine to coincide with the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.
ACR: Sustained Clinical Responses Seen With Neuroimmune Modulation for RA
THURSDAY, Nov. 12, 2026 (HealthDay News) — Twenty-four-month data show sustained clinical responses for patients receiving neuroimmune modulation therapy for rheumatoid arthritis, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in Orlando, Florida.
Serum Carotenoid Levels Have Positive Impact on COPD Health Status
Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in RA
Research Challenges Fusion for Lumbar Degenerative Spondylolisthesis
Treatment Satisfaction Higher for Patients With RA Choosing Their Own Treatment
β3 Agonists Do Not Cut Dementia Risk Versus Anticholinergics in OAB
CDC: 1 in 10 U.S. Adults Reported GLP-1 Medication Use July to August 2025
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers